ÄÐÈ˹¬µî Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology with a Focus on Oncology and Infectious Diseases May 9, 2022
Replay of the Evercore ISI COVID Dx Webinar with OPKO and BioReference Senior Leadership May 27, 2020
